$
Federal Contract Award
Novartis Pharmaceuticals Corporation
Department of Defense · June 18, 2026 · FY2026
HT941026FE065Full & OpenNAICS 325412
Obligated
$167,285
Contract details
- Award ID
- CONT_AWD_HT941026FE065_9700_HT941026AE002_9700
- PIID
- HT941026FE065
- Period of performance
- June 3, 2026 → September 30, 2026
- Place of performance
- EAST HANOVER, NJ, USA
- Set-aside
- None (Full & Open)
- Pricing type
- FIRM FIXED PRICE
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- NAICS
- 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
Scope
PLUVICTO AND LUTATHERA INJECTIONS
Parent vehicle (IDV)
Novartis Sanierungsstiftung
UEI YE3YG1FDWMC5
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Novartis Pharmaceuticals Corporation →- UEI
- NG61ZA8TADW3
- CAGE
- 04520
- Parent
- Novartis Sanierungsstiftung
- Address
- EAST HANOVER, NJ
Awarding agency
Department of Defense →- Sub-agency
- Defense Health Agency
- Office
- DEFENSE HEALTH AGENCY HCD WEST
- Funding agency
- Department of Defense
- Funding office
- NAV MED CTR SAN DIEGO CA - MM
See every contract Novartis Pharmaceuticals Corporation has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Novartis Pharmaceuticals Corporation profile →